Guidance Highlights Preclinical Testing Issues For Combination Products
This article was originally published in The Gray Sheet
A new guidance document from FDA discusses the types of scientific and technical data that may be needed to establish the safety and efficacy of novel combination products
You may also be interested in...
Multiple review cycles for emerging technologies would be reduced, but not entirely eliminated, if industry and FDA were to meet earlier in the product development process, the agency finds
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.